Rising breast cancer diagnosis rates and more aggressive disease in younger women underscore importance of early detection and care with effective and tolerable treatments that help prevent cancer ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

Radiologists interpret more than 40 million mammograms in the United States every year. In 2025, AI tools to help detect or ...

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated ...

The global market for digital breast tomosynthesis (DBT) equipment is forecasted to attain USD 3,267.6 million by 2025, ...

Researchers have discovered that, compared to breast cancer that is symptom-detected, patients with breast cancer detected ...

The global Breast Biopsy Devices Market, valued at US$2,255.0 million in 2024, is forecasted to grow at a robust CAGR of 6.5% ...

The data may change how patients are treated following a diagnosis for advanced triple-negative breast cancer, one expert ...